411 related articles for article (PubMed ID: 17478764)
21. BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
Trovisco V; Vieira de Castro I; Soares P; Máximo V; Silva P; Magalhães J; Abrosimov A; Guiu XM; Sobrinho-Simões M
J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508
[TBL] [Abstract][Full Text] [Related]
22. Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.
Poli R; Scatolini M; Grosso E; Maletta F; Gallo M; Liscia D; Nelva A; Cesario F; Forte G; Metovic J; Volante M; Arvat E; Papotti M
Endocrine; 2021 Jan; 71(1):216-224. PubMed ID: 32743766
[TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid cancer in a struma ovarii: a report of a rare case.
Monti E; Mortara L; Zupo S; Dono M; Minuto F; Truini M; Naseri M; Giusti M
Hormones (Athens); 2015; 14(1):154-9. PubMed ID: 25402391
[TBL] [Abstract][Full Text] [Related]
24. The lack of consensus in management of malignant struma ovarii.
González Aguilera B; Guerrero Vázquez R; Gros Herguido N; Sánchez Gallego F; Navarro González E
Gynecol Endocrinol; 2015 Apr; 31(4):258-9. PubMed ID: 25539066
[TBL] [Abstract][Full Text] [Related]
25. Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci.
Seo GT; Minkowitz J; Kapustin DA; Fan J; Minkowitz G; Minkowitz M; Dowling E; Matloob A; Asti D; Dhar M; Shutty C; Brickman A; Urken ML; Brandwein-Weber M; Finkelstein SD
Diagn Pathol; 2023 Apr; 18(1):47. PubMed ID: 37072862
[TBL] [Abstract][Full Text] [Related]
26. Malignant struma ovarii. A case report and literature review.
Gould SF; Lopez RL; Speers WC
J Reprod Med; 1983 Jun; 28(6):415-9. PubMed ID: 6887150
[TBL] [Abstract][Full Text] [Related]
27. Late struma ovarii diagnosis many years after total thyroidectomy. A rare entity.
Iavazzo C; Vorgias G; Psarrou A; Lekka I; Katsoulis M
J BUON; 2008; 13(4):573-4. PubMed ID: 19145683
[TBL] [Abstract][Full Text] [Related]
28. Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.
Smith RA; Salajegheh A; Weinstein S; Nassiri M; Lam AK
Hum Pathol; 2011 Apr; 42(4):500-6. PubMed ID: 21167555
[TBL] [Abstract][Full Text] [Related]
29. Malignant struma ovarii with a focus of papillary thyroid cancer: a case report.
Doganay M; Gungor T; Cavkaytar S; Sirvan L; Mollamahmutoglu L
Arch Gynecol Obstet; 2008 Apr; 277(4):371-3. PubMed ID: 17882443
[TBL] [Abstract][Full Text] [Related]
30. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases.
Devaney K; Snyder R; Norris HJ; Tavassoli FA
Int J Gynecol Pathol; 1993 Oct; 12(4):333-43. PubMed ID: 8253550
[TBL] [Abstract][Full Text] [Related]
31. Case report: Malignant struma ovarii.
Navarro MD; Tan MA; Lovecchio JL; Hajdu SI
Ann Clin Lab Sci; 2004; 34(1):107-12. PubMed ID: 15038677
[TBL] [Abstract][Full Text] [Related]
32. [BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma].
Cañadas Garre M; López de la Torre Casares M; Becerra Massare P; López Nevot MÁ; Villar Del Moral J; Muñoz Pérez N; Vílchez Joya R; Montes Ramírez R; Llamas Elvira JM
Endocrinol Nutr; 2011 Apr; 58(4):175-84. PubMed ID: 21441079
[TBL] [Abstract][Full Text] [Related]
33. Papillary type thyroid carcinoma in an ovarian struma.
O'Neill JP; Burns P; Kinsella J
Ir J Med Sci; 2012 Mar; 181(1):115-7. PubMed ID: 20339953
[TBL] [Abstract][Full Text] [Related]
34. Struma ovarii and the thyroid surgeon.
Gunasekaran S; Kopecka E; Maung KH; England RJ
J Laryngol Otol; 2012 Aug; 126(8):858-60. PubMed ID: 22624934
[TBL] [Abstract][Full Text] [Related]
35. Unilateral malignant struma ovarii in a case of bilateral ovarian teratoma with raised CA-125 level: a rare case with treatment dilemmas.
Menon S; Deodhar K; Rekhi B; John A; Maheshwari A
Indian J Pathol Microbiol; 2011; 54(3):578-80. PubMed ID: 21934226
[TBL] [Abstract][Full Text] [Related]
36. Papillary thyroid cancer arising in struma ovarii.
Jean S; Tanyi JL; Montone K; McGrath C; Lage-Alvarez MM; Chu CS
J Obstet Gynaecol; 2012 Apr; 32(3):222-6. PubMed ID: 22369392
[TBL] [Abstract][Full Text] [Related]
37. Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas.
Chuang TC; Chuang AY; Poeta L; Koch WM; Califano JA; Tufano RP
Head Neck; 2010 Feb; 32(2):229-34. PubMed ID: 19626635
[TBL] [Abstract][Full Text] [Related]
38. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
39. It Does Exist! Diagnosis and Management of Thyroid Carcinomas Originating in Struma Ovarii.
Smith LP; Brubaker LW; Wolsky RJ
Surg Pathol Clin; 2023 Mar; 16(1):75-86. PubMed ID: 36739168
[TBL] [Abstract][Full Text] [Related]
40. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
Cañadas-Garre M; Becerra-Massare P; López de la Torre-Casares M; Villar-del Moral J; Céspedes-Mas S; Vílchez-Joya R; Muros-de Fuentes T; García-Calvente C; Piédrola-Maroto G; López-Nevot MA; Montes-Ramírez R; Llamas-Elvira JM
Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
